biomarkers in the diagnosis and management of sepsis and covid-19 (session 2 – 2022 wsc spotlight)
Published 2 years ago • 1.9K plays • Length 1:27:35Download video MP4
Download video MP3
Similar videos
-
2:39:16
wsc spotlight - updates on sepsis
-
1:25:54
knowledge from covid-19 to improve sepsis care and vice versa (session 3 – 2022 wsc spotlight)
-
58:13
pro-con: are personalized interventions in sepsis even possible? (session 7 – 2022 wsc spotlight)
-
1:06:51
update on adjunctive sepsis and covid-19 therapies (session 6 – 2022 wsc spotlight)
-
1:37:13
could enhanced pathogen diagnostics change sepsis management? (session 1 – 2022 wsc spotlight)
-
42:08
sepsis - diagnosis and management of sepsis: the value of biomarkers and rapid microbiology | us
-
1:11:50
critical connections live: new guidelines for the management of sepsis and septic shock
-
1:56
what is a biomarker?
-
1:14:50
2020 wsc spotlight – the epidemiology and burden of sepsis
-
1:29:51
2nd wsc - antimicrobial therapy and source control i (session 2)
-
1:45:00
wsc 2021–global standards & guidelines for the management of sepsis & covid-19 patients (session 15)
-
1:18:10
innovations in quality improvement strategies in all settings (session 8 – 2022 wsc spotlight)
-
1:36:12
wsc 2021 – impactful trials and innovative trial design in sepsis and covid-19 (session 11)
-
2:08:03
2020 wsc spotlight – opening session
-
1:30:55
2nd wsc - importance of pathogen detection and sepsis markers (session 6)
-
1:36:52
1st wsc - pathogen detection and sepsis markers i
-
1:42:00
2020 wsc spotlight – sepsis, ebola, and covid-19
-
1:39:37
1st wsc - pathogen detection and sepsis markers ii
-
1:32:42
wsc 2021 – combating sepsis is a great patient safety strategy (session 2)
-
0:47
2022 wsc spotlight – trailer – a free online congress by the gsa, april 27, 2022
-
1:41:20
wsc 2021 – immunomodulatory treatments in sepsis and severe covid-19 (session 14)
-
1:42:23
2nd wsc - antimicrobial therapy and source control ii (session 7)